Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook
Go back to Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook| (NASDAQ: EOLS) | Delayed: 6.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.97 | 52 Week High | $ | |||
| Open | $6.97 | 52 Week Low | $ | |||
| Day High | $6.97 | P/E | N/A | |||
| Day Low | $6.97 | EPS | $ | |||
| Volume | 74 | |||||

